Biotech - Spark Newswire

3 minute read

Additional Interim Data From Phase I/II/III CAMPSIITE Trial Of REGENXBIO’s RGX-121 For The Treatment Of MPS II (Hunter Syndrome) Presented At 19th Annual WORLDSymposium

Today, 5:05 AM

RGX-121, a potential one-time gene therapy for the treatment of MPS II, continues to be well-tolerated with no drug-related SAEs across three dose levels Additional data from patients in Cohort 3 using pivotal program

RGNX

1 minute read

Analyst Sees Attractive Entry Opportunity After BioCryst’s Pipeline Setback

By Vandana Singh

Today, 5:05 AM

Tucked in its Q4 earnings press release, BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) reported a setback on the early-stage BCX10013 study. The company…

BCRX

1 minute read

Immunocore Reveals First Data From HIV Infection Candidate Study

By Vandana Singh

Today, 5:05 AM

Immunocore Holdings plc (NASDAQ:IMCR) has presented the first safety and activity data with IMC-M113V, a bispecific soluble TCR therapy built on…

IMCR

3 minute read

Gilead Presents Proof-Of-Concept Data For Investigational Combination Regimen Of Lenacapavir With Broadly Neutralizing Antibodies As A Potential Twice-Yearly Approach For The Treatment Of HIV

By Happy Mohamed

Today, 5:05 AM

– Study Demonstrates the Potential of Lenacapavir in Combination with Broadly Neutralizing HIV Antibodies Teropavimab and Zinlirvimab – – Findings Support Further Evaluation of the Investigational

GILD

2 minute read

Co-Diagnostics, Inc. Initiates Clinical Evaluations For Its At-Home And Point-Of-Care Co-Dx PCR Home Platform

By Happy Mohamed

Today, 5:05 AM

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced

CODX

2 minute read

Ovia Health Expands Digital Platform Capabilities To Include Menopause Tracking

By Happy Mohamed

Today, 5:05 AM

Digital platform expansion provides women access to resources for their unique health care needs Ovia Health, a trusted digital health platform for women and families, today announced the expansion of its Ovia® app,

2 minute read

Eterna Therapeutics Enters Into Option And License Agreement With Lineage Cell Therapeutics To Develop Hypoimmune Pluripotent Cell Lines For Multiple Neurology Indications

By Happy Mohamed

Today, 5:05 AM

Eterna Therapeutics Inc. (NASDAQ:ERNA) ("Eterna"), a preclinical-stage biotechnology company committed to realizing the potential of mRNA cell engineering to provide patients with transformational

ERNA

1 minute read

ProPhase Labs Announces Plans To Initiate Clinical Trial Of Equivir, Goal To Launch Commercially In Q4 2023

By Happy Mohamed

Today, 5:05 AM

ProPhase Labs, Inc. (NASDAQ:PRPH) ("ProPhase"), a growth oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly-owned subsidiary, ProPhase BioPharma, Inc. (PBIO), is

PRPH

1 minute read

Astrazeneca’s Tablet Formulation Of Calquence (Acalabrutinib) Has Been Approved In The European Union (Eu) For Adult Patients With Chronic Lymphocytic Leukemia.

By Benzinga Newsdesk

Today, 5:05 AM

The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use and is based on results from the ELEVATE-PLUS trials published in the American Society of

AZN

6 minute read

Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More

By Lara Goldstein

Today, 5:05 AM

Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and added to the list of measures calling for some sort of psychedelics legalization, while some of the already filed ones continue progressing and others get a thumbs down.

AGNPF